CDC Eyes Bavarian Monkeypox Vaccine for Kids as Outbreak Spreads
- CDC sees 500,000 courses of vaccine delivered this year
- Almost half of infections acquired locally, CDC documents show
This article is for subscribers only.
US health officials are looking to expand use of the monkeypox vaccine for children as the outbreak continues to spread across the US and in countries around the world, with more than 3,300 cases reported globally.
The US Centers for Disease Control and Prevention is developing a protocol aimed at allowing use of Bavarian Nordic A/S’s Jynneos vaccine in children, if needed, according to documents prepared for a meeting of agency advisers that took place this week. The vaccine is currently cleared for use in adults and is considered safer than Emergent BioSolutions Inc.’s ACAM2000 smallpox vaccine, which can also be used against monkeypox.